151
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Autoimmune Acquired Factor XIII Deficiency: A Case Report

ORCID Icon & ORCID Icon
Pages 63-68 | Published online: 09 Feb 2021

References

  • Komaromi I, Bagoly Z, Muszbeck L. Factor XIII: novel structural and functional aspects. J Thromb Haemost. 2011;9:9–20. doi:10.1111/j.1538-7836.2010.04070.x
  • Levy JH, Greenberg C. Biology of factor XIII and clinical manifestations of factor XIII deficiencies. Transfusion. 2013;53:1120–1131. doi:10.1111/j.1537-2995.2012.03865.x
  • Muszbek L, Penzes K, Katona E. Auto and alloantibodies against factor XIII: laboratory diagnosis and clinical consequences. J Thromb Haemost. 2018;16:822–832. doi:10.1111/jth.13982
  • Ichinose A, Kohler HP, Philippou H; on behalf of the Factor XIII and Fibrinogen SSC Subcommittee of the ISTH. Recommendations for ISTH/SSC criterion 2015 for autoimmune acquired factor XIII/13 deficiency. Thromb Haemost. 2016;116:772–774. doi:10.1160/TH-16-05-0362
  • Baudo F, Colllins P, Huth-kuhne A, et al. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) registry. Blood. 2012;120:39–46. doi:10.1182/blood-2012-02-408930
  • Ichinose A; on behalf of the Japanese Collaborative Research Group on AH13. Autoimmune acquired factor XIII deficiency due to anti-factor XIII/13 antibodies: a summary of 93 patients. Blood Rev. 2017;31:37–45. doi:10.1016/j.blre.2016.08.002
  • Muszbek L, Katona E. Diagnosis and management of congenital and acquired FXIII deficiencies. Semin Thromb Hemost. 2016;42:429–439. doi:10.1055/s-0036-1572326
  • Duncan E, Collecutt M, Street A. Nijmegen-bethesda assay to measure factor VIII inhibitors. Methods Mol Biol. 2013;992:321–333.
  • Hemker H, Giesen P, Al Dieri R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb. 2003;33:4–15. doi:10.1159/000071636
  • Kohler HP, Ichinose A, Seitz R, Ariens AR, Muszbek L. on behalf of the factor XIII and fibrinogen SSC subcommittee of the ISTH. J Thromb Haemost. 2011;9:1404–1406. doi:10.1111/j.1538-7836.2011.04315.x
  • Ghosh K, Mota L, Shetty S, Kulkarni B. Spectrum of changes in endogenous thrombin potential due to heritable disorders of coagulation. Blood Coagul Fibrinolysis. 2008;19:577–580. doi:10.1097/MBC.0b013e328307089d
  • Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN. Hemostasis and Thrombosis: Basic Principles and Clinical Practice.Lippincott Williams & Wilkins.2006. Vol. 319. 1078–1079.
  • Theusinger OM, Baulig W, Asmis LM, Seifert B, Spahn DR. In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM). Thromb Haemost. 2010;104:385–391. doi:10.1160/TH09-12-0858
  • Sheng Yan MT, Rydz N, Goodyear D, Sholzberg M. Acquired factor XIII deficiency: a review. Transfus Apher Sci. 2018;57:724–730. doi:10.1016/j.transci.2018.10.013
  • Boehlen F, Casini A, Chizzolini C, et al. Acquired factor XIII deficiency: a therapeutic challenge. Thromb Haemost. 2013;109:479–487. doi:10.1160/TH12-08-0604
  • Franchini M, Frattini F, Crestani S, Bonfanti C. Acquired FXIII inhibitors: a systematic review. J Thromb Thrombolysis. 2013;36:109–114. doi:10.1007/s11239-012-0818-3
  • Di Micco P, Gussoni G, Pieralli F, Campanini M, Dentali F, Fontanella A. Acquired factor XIII deficiency inducing recurrent and fatal bleeding, description of a case. J Blood Med. 2020;11:43–45. doi:10.2147/JBM.S232115
  • Kessel R, Hu C, Shore-Lesserson L, Rand J, Manwani D. A child with acquired factor XIII deficiency: case report and literature review. Haemophilia. 2013;19:814–826. doi:10.1111/hae.12145